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The increasing demand for organ allografts to treat end-stage organ failure has driven changes in traditional donor
criteria. Patients who have succumbed to carbon monoxide (CO) poisoning, a common cause of toxicological
mortality, are usually rejected as organ donors. To fulfill the increasing demand, selection criteria must be expanded
to include CO-poisoned donors. However, the use of allografts exposed to high CO concentrations is still under
debate. Basic research and literature review data suggest that patients with brain death caused by CO poisoning
should be considered appropriate organ donors. Accepting organs from CO-poisoned victims could increase the
number of potential donors and lower the death rate of patients on the waiting lists. This review and reported
cases may increase awareness among emergency department physicians, as well as transplant teams, that patients
dying of CO exposure may be acceptable organ donors.Introduction
The success of organ transplantation has led to a grow-
ing imbalance between the supply and demand of donor
organs. Accordingly, the use of organs from nonconven-
tional donors, such as those who die from carbon monox-
ide (CO) poisoning, has increased. Organ procurement is
based on criteria that exclude as potential donors those
who have undergone prolonged cardiopulmonary resusci-
tation (CPR), those with certain metabolic diseases, and
those with infectious diseases such as human immuno-
deficiency virus (HIV), hepatitis, sepsis, tuberculosis, and
metastatic disease. These exclusion criteria result in a
donor shortage despite an increasing number of individ-
uals waiting for organ transplants.
CO is well-known in clinical medicine for its toxicity,
which is due to its ability to interfere with oxygen delivery.
Traditionally, CO poisoning has been considered a contra-
indication to organ procurement. The possibility of organ
procurement from donors who died of CO poisoning has
been discussed in the scientific literature. The possibility
of permanent and significant injury to transplanted organs
caused by CO may raise serious concerns regarding the
procedure. However, a number of publications report* Correspondence: atsunorinakao@aol.com
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unless otherwise stated.successful organ transplantation from donors who were
brain dead as a result of CO poisoning. Therefore, the be-
lief that this poisoning automatically contraindicates do-
nation of organs, including the heart, kidney, liver, may be
unfounded.
CO has recently raised scientific and clinical interest,
as its beneficial effects and mechanisms of action have
been substantially defined in various in vitro and in vivo
studies [1]. Although CO is generally known as a toxic
gas, it is endogenously produced in the body and func-
tions as an important signaling gas molecule, providing
potent cytoprotective effects [2,3]. These research findings
may support the idea that CO-poisoned donors should be
considered appropriate for organ transplantation.
The use of organs from CO-poisoned victims for the
purpose of transplantation has been poorly studied; cri-
teria for organ donation are virtually non-existent in such
cases [4,5]. The aim of this review is to provide an outline
of previous reports of transplants from CO-poisoned do-
nors, as well as current knowledge from CO-related clin-
ical studies. In particular, emergency physicians must be
aware that patients dying from CO exposure may be ac-
ceptable organ donors, because the emergency depart-
ment is a critical site for organ procurement.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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While CO poisoning is common, its incidence is uncertain
and frequently unrecognized, as the signs and symptoms
are relatively nonspecific [6]. Unfortunately, no marker or
constellation of signs or symptoms at presentation predict
long-term outcome following CO poisoning [7,8]. Given
the neurocognitive sequelae following CO poisoning, in-
creased awareness and prevention of CO poisoning is im-
perative [9].
CO has a 200 times greater chemical affinity for
hemoglobin than oxygen. The mechanisms of tissue
damage due to CO poisoning are as follows: oxygen de-
livery to the tissues is reduced due to the high chemical
affinity of CO to hemoglobin, resulting in the shift of
the oxyhemoglobin dissociation curve to the left, and
CO strongly binds to myoglobin, interfering with oxy-
gen transportation to the mitochondria.
Various studies have demonstrated that CO interferes
with myoglobin, P450, and other enzyme functions;
causes lipid peroxidation through neutrophil activation;
produces oxidative stress manifested by peroxynitrate
deposition in endothelium; binds to cytochrome A3, dis-
rupting intracellular oxygen utilization; can cause neu-
roexcitotoxicity; and contributes to hippocampal cellular
death through apoptosis [10]. The tissues most affected
are those most sensitive to oxygen deprivation, specifically
those of the central nervous system and myocardium. In-
dividual susceptibility varies and symptoms depend on de-
gree of exposure (concentration, duration, and ventilation
volume), tissue metabolic demands, concurrent anemia,
and preexisting atherosclerosis.
Usually patients with CO poisoning also suffer from
burns. Of note, admission to the hospital after a fire ac-
cident may have been exposed the patient to cyanide
gases as well as CO [11].
A comparison between successful and unsuccessful
transplantation cases with CO-poisoned donor organs
would be quite interesting. Identifying some key charac-
teristics of CO-poisoned donors would be beneficial for
future application. However, unfortunately, most of the re-
ports were single case reports or poorly described without
detailed data, including data on COHb levels, CO poison-
ing time, and clinical course.
Donor treatment with CO: basic research data
CO potently protects against cellular injury. CO relaxes
blood vessels and exerts anti-thrombotic effects by inhi-
biting platelet aggregation and derepressing fibrinolysis.
In addition, CO reduces ischemia/reperfusion injury and
inflammatory responses. CO inhibits apoptosis of endo-
thelial and epithelial cells and reduces proliferation of
smooth muscle cells, fibroblasts, and T lymphocytes.
Thus, accumulating evidence supports the notion that
CO treatment of transplant donors, organs, or recipientscan prevent graft dysfunction due to rejection or ische-
mia/reperfusion injury.
Several studies have demonstrated that donor pretreat-
ment with CO benefits graft function in animal models.
In an islet allograft model, donor CO pretreatment
blocked toll-like receptor-4 upregulation, diminishing
the inflammatory response and cytokine-induced apop-
tosis, which protected the graft from rejection [12]. Do-
nors who have inhaled CO or suffered cold ischemia
with CO perfusion have demonstrated improved graft
function, which was associated with decreased apoptosis
and increased viability of endothelial cells and cardio-
myocytes [13]. Induction of CO in the donor by oral ad-
ministration of methylene chloride was able to prevent
chronic rejection of rat renal allografts [14]. Donors
treated with CORM-2 presented fewer lymphocytic infil-
trates and reduced acute tubular necrosis in the graft
[15]. This protection was most likely related to CO-
induced endothelial changes via a reduction in NADPH-
dependent superoxide anion production, IkB degradation,
and E-selectin and ICAM-1 expression [15]. Studies on
CO’s mechanism of action have shown that it binds to the
heme moiety of soluble guanylyl cyclase (sGC), leading to
cyclic guanosine monophosphate (cGMP) activation [16].
As shown above, donor treatment with CO was bene-
ficial for the survival of several types of organ grafts such
as the heart, kidney, liver, and lung in animal models; we
might anticipate similar efficacies of CO in grafts har-
vested from CO-poisoned donors in humans.
Clinical reports
Several studies report the successful use of CO-poisoned
victims as organ allograft donors (Table 1). Bojakowski
et al. reported a single case of renal transplantation with
grafts retrieved from a CO-poisoned donor. Despite pro-
longed warm ischemic time (>100 minutes), no compli-
cations were observed in the post-transplant course,
suggesting that CO diminished ischemia/reperfusion in-
jury and rejection [17]. Luckraz et al. described their ex-
perience with seven patients who were transplanted using
organs after fatal CO poisoning (six heart transplants and
one single lung transplant). History of CO inhalation was
obtained in all of these donors. Five of the six heart trans-
plant patients were alive and well at the time of the study,
with survival ranging from 68 to 1,879 days. One patient
(a 29-year-old male) died 12 hours post-transplant due to
donor organ failure. The patient who had a right single
lung transplant did well initially after the transplant, but
died after eight months due to Pneumocystis carinii pneu-
monia. All recipients who were transplanted from CO-
poisoned donors and ventilated for more than 36 hours
survived for more than 30 days [18].
Koerner et al. reported five cardiac allografts from
brain-dead, CO-poisoned donors. Donor history showed
Table 1 List of the past report using CO-poisoned victims as organ allograft donors
Year Author Journal # of donors Reference
1989 Karwande, et el. J Heart Transplant 1 heart [19]
1992 Hebert MJ, et al. N Engl J Med 6 kidneys [20]
1992 Shennib H et al. J Heart Lung Transplant 1 lung [21]
1992 Smith JA, et al. J Heart Lung Transplant 2 hearts [22]
1993 Iberer F, et al. J Heart Lung Transplant 1 heart [23]
1994 Leikin JB, et al. Am J Emerg Med 10 kidneys, 3 livers [4]
1995 Roberts JR et al. Ann Emerg Med 1 heart [24]
1995 Hantson P, et al. J Toxicol Clin Toxicol 1 kidney [25]
1996 Verran D, et al. Transplantation 2 livers [26]
1997 Koerner MM, et al. Transplantation 5 hearts [27]
2001 Rodrigus IE, et al. J Heart Lung Transplant 1 heart [28]
2001 Bentley MJ, et al. Ann Thorac Surg 2 hearts, 2 kidneys, 1 pancreas [29]
2001 Luckraz H, et al. Ann Thorac Surg 6 hearts, 1 lung [18]
2007 Bojakowski K, et al. Transplant Proc 1 kidney [17]
2008 Sezgin A, et al. Transplant Proc 1 heart [30]
2008 Martin-Suarez S, et al. Transplant Proc 1 heart [31]
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plantation, donor hemodynamic parameters were weak
in all patients. The postoperative course was uneventful
in three of the five recipients. The overall three-year sur-
vival rate in this small group was 40%. Induction therapy
or rescue therapy with mono/polyclonal antibodies was
not necessary. Myocardial right-ventricular biopsies did
not show any specific signs of CO-poisoning [27].
Verran et al. reported two successful liver transplant
cases using CO-poisoned donors. There was satisfactory
early function of both allografts, although marked patchy
necrosis was seen on the postreperfusion biopsy (case 1)
and on a 10 day postoperative biopsy (case 2). In both
cases, the changes were considered to be related to dam-
age sustained from CO inhalation. Both allografts soon
achieved normal function and both recipients were well at
the time of the study. They concluded that CO-poisoning
can cause liver damage that can recover completely fol-
lowing liver transplantation. Shennib et al. reported a
single case of successful lung transplantation using a
CO-poisoned donor [21]. Sezgin et al. presented a pa-
tient who underwent a successful cardiac transplantation
from a brain-dead donor who had CPR after CO intoxica-
tion. Although the donor had a history of CPR, the left
ventricular ejection fraction was 55% and the echocardio-
graphic evaluation revealed normal cardiac contractions
with acceptable hemodynamic parameters. While positive
inotropic support was needed in the early postoperative
period, any changes related to intoxication in the endo-
myocardial biopsy was not observed [30].
On the other hand, contradictory evidence concerning
this topic has also been published. Karwande et al.presented a case of CO poisoning that led to severe
myocardial damage in the transplanted heart [19].
Hantson et al. reported one case of kidney transplantation
from a CO-poisoned donor. In this case, the recipient was
extremely unstable and the graft was rejected within a few
months [25]. Rodrigus et al. presented a case of CO poi-
soning in a multiorgan donor that led to primary cardiac
allograft failure. A biventricular assist device was used as a
bridge to recovery [28].
Considering the significant risk of donor organ failure, a
cautious approach is still warranted. A formal approach of
invasive monitoring and active management further im-
proves the chances of successful outcome. Predicting
organ damage by blood carboxy-hemoglobin levels is
quite challenging because very poor correlation has
been found between blood carboxy-hemoglobin level,
tissue carboxy-hemoglobin level, and degree of organ
damage [32].
In general, little data regarding long-term survival are
available, but individual reported cases suggest that the
survival of patients transplanted with organs procured
from carefully selected CO-poisoned donors may be
comparable to that of patients transplanted from non-
poisoned donors. While these reports do not support
the use of CO therapeutically during transplantation per
se, they certainly do not provide any evidence that con-
traindicates it.
Conclusion
Currently, it is estimated that less than 1% of all donated
organs in Western Europe and the USA are procured
from CO-poisoned donors [33]. Although reports of
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CO-poisoned donors have been published, there have also
been reports of donor organ failure, resulting in early re-
cipient death. Thus, the use of these organs for transplan-
tation remains controversial, as little data exists from
which to draw any firm conclusion. Since CO poisoning is
common, organs procured from CO-poisoned donors
could save the lives of those on donor waiting lists.
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